Publicaciones en colaboración con investigadores/as de Uppsala University (13)

2023

  1. Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial

    Annals of surgery, Vol. 278, Núm. 4, pp. e766-e772

  2. The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer—results from the RAPIDO trial

    ESMO Open, Vol. 8, Núm. 2

2021

  1. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 1, pp. 29-42

2020

  1. Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

    Radiotherapy and Oncology, Vol. 147, pp. 75-83

  2. Erratum to “Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial” [Radiother. Oncol. 147 (2020) 75–83] (Radiotherapy and Oncology (2020) 147 (75–83), (S0167814020301201), (10.1016/j.radonc.2020.03.011))

    Radiotherapy and Oncology

2019

  1. A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, pp. iv36

  2. Definition of the rectum: An International, expert-based Delphi consensus

    Annals of Surgery, Vol. 270, Núm. 6, pp. 955-959

2016

  1. PAN-EX: A pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

    Annals of Oncology, Vol. 27, Núm. 8, pp. 1557-1565

  2. Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

    Carcinogenesis, Vol. 37, Núm. 9, pp. 852-857

2015

  1. Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial

    Annals of Oncology, Vol. 26, Núm. 9, pp. 1936-1941

2014

  1. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

    European Journal of Cancer, Vol. 50, Núm. 1, pp. 1.e1-1.e34

2013

  1. EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

    European Journal of Cancer, Vol. 49, Núm. 13, pp. 2784-2790

2012

  1. Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    Annals of Oncology, Vol. 23, Núm. 10, pp. 2479-2516